Earlier and more confident detection of disease
Where it cannot intervene in the onset of disease, Imperial College AHSC aims to detect and diagnose health conditions earlier and more precisely.
Outcomes are improved and costs are reduced when conditions are diagnosed and treated early.
Drawing on the fullest range of academic strengths of its partners the AHSC is focused on developing and evaluating new detection technologies within the patient populations that it serves.
Developments in imaging, identification of novel biomarkers of disease and the application of new technologies developed in the Imperial Faculties of Engineering and Natural Sciences underpins the AHSC’s Better Detection agenda.
The AHSC’s priority programmes using informatics and artificial intelligence approaches includes a focus on the clinical challenges raised by the AHSC’s Diseases in focus to provide:
- big data approaches and pattern recognition of patients’ clinical information to identify early disease signals
- AI approaches in imaging to support clinical decision support in cancer, cardiovascular and brain disease
- AI and machine learning to assist pathology diagnosis
- detection of gastrointestinal cancer using analysis of exhaled breath
- new bronchoscopic techniques to biopsy lung tissue including robotic navigation
- evaluation of genetics and other emerging diagnostic biomarkers to improve the precision of disease diagnosis